<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vmireaviz</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник медицинского института «РЕАВИЗ». Реабилитация, Врач и Здоровье</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2226-762X</issn><issn pub-type="epub">2782-1579</issn><publisher><publisher-name>РЕАВИЗ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20340/vmi-rvz.2022.2.CLIN.7</article-id><article-id custom-type="elpub" pub-id-type="custom">vmireaviz-444</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Клиническая медицина</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Clinical medicine</subject></subj-group></article-categories><title-group><article-title>Криптогенный инсульт при фибрилляции предсердий без внутрисердечного тромба: возможные механизмы</article-title><trans-title-group xml:lang="en"><trans-title>Cryptogenic stroke in atrial fibrillation without intra-heart thrombi: possible mechanisms</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4833-4563</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Германова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Germanova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, директор Международного НОЦ Кардиоваскулярной патологии и кардиовизуализации</p><p>Самара</p></bio><bio xml:lang="en"><p>MD, PhD, director of International Centre for Educationand Research in Cardiovascular pathology and cardiovisualization</p><p>Samara</p></bio><email xlink:type="simple">olga_germ@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0367-7776</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Германов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Germanov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>кандидат медицинских наук, доцент кафедры пропедевтической терапии</p><p>Самара</p></bio><bio xml:lang="en"><p>PhD, MD, associate professor of chair of propedeuticaltherapy</p><p>Samara</p></bio><email xlink:type="simple">rean1mator2323@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8001-1249</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Галати</surname><given-names>Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Galati</surname><given-names>G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач-кардиолог</p><p>Милан</p></bio><bio xml:lang="en"><p>MD, cardiologist</p><p>Milan</p></bio><email xlink:type="simple">giuseppe.galati5@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2734-1457</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Прохоренко</surname><given-names>И. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Prokhorenko</surname><given-names>I. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор</p><p>Самара</p></bio><bio xml:lang="en"><p>MD, PhD, full professor</p><p>Samara</p></bio><email xlink:type="simple">ingaproch@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4239-5066</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Германов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Germanov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>врач по рентгенэндоваскулярной диагностике и лечению отделения рентгенхирургических методов диагностики и лечения клиники факультетской хирургии</p><p> Самара</p></bio><bio xml:lang="en"><p>MD, x-ray-endovascular diagnostics and treatment doctor faculty surgery clinics</p><p>Samara</p></bio><email xlink:type="simple">rean1mator2323@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Самарский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Samara State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Госпиталя им. Святого Рафаэля</institution><country>Италия</country></aff><aff xml:lang="en"><institution>Ospedale San Raffaele</institution><country>Italy</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Медицинский университет «Реавиз»</institution><country>Italy</country></aff><aff xml:lang="en"><institution>Reaviz Medical University</institution><country>Italy</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>11</day><month>05</month><year>2022</year></pub-date><volume>12</volume><issue>2</issue><fpage>80</fpage><lpage>89</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Германова О.А., Германов А.В., Галати Д., Прохоренко И.О., Германов В.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Германова О.А., Германов А.В., Галати Д., Прохоренко И.О., Германов В.А.</copyright-holder><copyright-holder xml:lang="en">Germanova O.A., Germanov A.V., Galati G., Prokhorenko I.O., Germanov V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestnik.reaviz.ru/jour/article/view/444">https://vestnik.reaviz.ru/jour/article/view/444</self-uri><abstract><p>До 45 % ишемических инсультов являются крипрогенными.</p><p>Цель – изучить, какой вариант перманентной фибриляции предсердий (ФП) без внутрисердечных тромбов является наиболее неблагоприятным в возникновении инсульта.</p><sec><title>Методы</title><p>Методы. Под нашим наблюдением находилось 202 пациента с постоянной формой ФП без внутрисердечных тромбов и с гемодинамически незначимым атеросклеротическим стенозом каротидной бифуркации. Проводили эхокардиографию, суточное мониторирование электрокардиографии (ЭКГ), УЗИ брахиоцефальных артерий, сфигмографию общих сонных артерий, компьютерную томографию головного мозга, гемостазиограммы, липидограмму, гемоглобин А1с. По данным суточного мониторирования ЭКГ мы разделили пациентов на две группы в зависимости от максимальных пауз между желудочковыми комплексами при ФП: пациенты с паузой &lt;1,5 с (113 человек); ≥1,5 с (89 человек). Обе группы получали одинаковую стандартную терапию, включая новые пероральные антикоагулянты. Мы наблюдали пациентов втечение одного года для анализа верифицированного инсульта или транзиторной ишемической атаки (ТИА).Полученные результаты. При УЗИ отмечено увеличение линейной скорости кровотока в зоне каротидного стеноза при распространении пульсовой волны после длительной паузы между сокращениями желудочков во 2-й группе до 2,5 м/с, как и при гемодинамически значимом стенозе. При однолетнем наблюдении частота инсультов была выше во 2-й группе.</p></sec><sec><title>Заключение</title><p>Заключение. Возникновение инсульта и ТИА при ФП выше у пациентов, имеющих паузы максимальной продолжительности 1,5 с и более между сокращениями желудочков. Причиной криптогенного инсульта может быть дефрагментация атеросклеротической бляшки с последующей эмболией, обусловленная дополнительным механическим воздействием повышенных гемодинамических параметров пульсовой волны после длительной паузы между сокращениями желудочков.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Up to 45% of ischemic strokes are cryprogenic.</p><p>Aim is to study which variant of permanent AF without intra-heart thrombi is the most unfavorable in appearing of stroke.</p></sec><sec><title>Methods</title><p>Methods. We observed 202 patients with permanent AF without intra-heart thrombi and hemodynamically not significant carotid bifurcation atherosclerotic stenosis. We performed echocardiography, 24-hours monitoring of electrocardiography (ECG), ultrasound of brachiocephalic arteries, sphygmography of common carotid arteries, computer tomography of the brain, hemostasiograms, lipid profile, hemoglobin A1c. According to the 24-hours ECG monitoring data, we divided patients into two groups up to the maximum pauses between ventricular complexes in AF: patients with a pause &lt;1,5 seconds (113); ≥1,5 seconds (89). Both groups were on the same standard therapy including novel oral anticoagulants. We observed the patients during 1 year to analyze the verified stroke or transient ischemic attack (TIA).</p></sec><sec><title>Results</title><p>Results. In ultrasound, there was an increase of linear blood flow velocity in the area of carotid stenosis during the spread of the pulse wave after the long pause between ventricular contractions in group 2 up to 2,5 m/sec as in hemodynamically significant stenosis. In 1-year observation, there was the higher stroke in group 2.</p></sec><sec><title>Conclusion</title><p>Conclusion. The appearance of stroke and TIA in AF is higher in patients who have 1,5 seconds and more of maximum duration pauses between ventricular contractions. The reason of cryptogenic stroke can be the atherosclerotic plaque defragmentation with further embolism, caused by additional mechanical impact of increased hemodynamical parameters of pulse wave after long pause between ventricular contractions.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>криптогенный инсульт</kwd><kwd>фибрилляция предсердий</kwd><kwd>кинетика магистральных артерий</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cryptogenic stroke</kwd><kwd>atrial fibrillation</kwd><kwd>main arteries kinetics</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24. Erratum in: Stroke. 2021 Jul;52(7):e483-e484. PMID: 34024117.</mixed-citation><mixed-citation xml:lang="en">Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021 Jul;52(7):e364-e467. doi: 10.1161/STR.0000000000000375. Epub 2021 May 24. Erratum in: Stroke. 2021 Jul;52(7):e483-e484. PMID: 34024117.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al; on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2020 update: a report from the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757</mixed-citation><mixed-citation xml:lang="en">Virani SS, Alonso A, Benjamin EJ, Bittencourt MS, Callaway CW, Carson AP, et al; on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics–2020 update: a report from the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2017. http://ghdx.healthdata.org/gbd-results-tool. Accessed March 15, 2018.</mixed-citation><mixed-citation xml:lang="en">Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2017. http://ghdx.healthdata.org/gbd-results-tool. Accessed March 15, 2018.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kleindorfer D, Panagos P, Pancioli A, Khoury J, Kissela B, Woo D, et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke. 2005;36:720–723. doi: 10.1161/01.STR.0000158917.59233.b7</mixed-citation><mixed-citation xml:lang="en">Kleindorfer D, Panagos P, Pancioli A, Khoury J, Kissela B, Woo D, et al. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke. 2005;36:720–723. doi: 10.1161/01.STR.0000158917.59233.b7</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet. 2018; 392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7</mixed-citation><mixed-citation xml:lang="en">James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.Lancet. 2018; 392:1789–1858. doi: 10.1016/S0140-6736(18)32279-7</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, et al. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet Neurol. 2019; 18:439–458.</mixed-citation><mixed-citation xml:lang="en">Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, et al. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet Neurol. 2019; 18:439–458.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al.. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet. 2017; 390:1151–1210. doi: 10.1016/S0140-6736(17)32152-9</mixed-citation><mixed-citation xml:lang="en">Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, et al.. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.Lancet. 2017; 390:1151–1210. doi: 10.1016/S0140-6736(17)32152-9</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, et al. European Cardiovascular Disease Statistics 2017. Brussels: European Heart Network; 2017.</mixed-citation><mixed-citation xml:lang="en">Wilkins E, Wilson L, Wickramasinghe K, Bhatnagar P, Leal J, Luengo-Fernandez R, et al. European Cardiovascular Disease Statistics 2017. Brussels: European Heart Network; 2017.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bennett DA, Krishnamurthi RV, Barker-Collo S, Forouzanfar MH, Naghavi M, Connor M, et al.; Global Burden of Diseases, Injuries, and Risk Factors 2010 Study Stroke Expert Group. The global burden of ischemic stroke: findings of the GBD 2010 study. Glob Heart. 2014; 9:107–112. doi: 10.1016/j.gheart.2014.01.001</mixed-citation><mixed-citation xml:lang="en">Bennett DA, Krishnamurthi RV, Barker-Collo S, Forouzanfar MH, Naghavi M, Connor M, et al.; Global Burden of Diseases, Injuries, and Risk Factors 2010 Study Stroke Expert Group. The global burden of ischemic stroke: findings of the GBD 2010 study. Glob Heart. 2014; 9:107–112. doi: 10.1016/j.gheart.2014.01.001</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kunst AE, Amiri M, Janssen F. The decline in stroke mortality: exploration of future trends in 7 Western European countries. Stroke. 2011; 42:2126–2130. doi: 10.1161/STROKEAHA.110.599712</mixed-citation><mixed-citation xml:lang="en">Kunst AE, Amiri M, Janssen F. The decline in stroke mortality: exploration of future trends in 7 Western European countries. Stroke. 2011; 42:2126–2130. doi: 10.1161/STROKEAHA.110.599712</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet. 2012; 380:2197–2223. doi: 10.1016/S0140-6736(12)61689-4</mixed-citation><mixed-citation xml:lang="en">Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet. 2012; 380:2197–2223. doi: 10.1016/S0140-6736(12)61689-4</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zahra A, Lee EW, Sun LY, Park JH. Cardiovascular disease and diabetes mortality, and their relation to socio-economical, environmental, and health behavioural factors in worldwide view. Public Health. 2015; 129:385–395. doi: 10.1016/j.puhe.2015.01.013</mixed-citation><mixed-citation xml:lang="en">Zahra A, Lee EW, Sun LY, Park JH. Cardiovascular disease and diabetes mortality, and their relation to socio-economical, environmental, and health behavioural factors in worldwide view. Public Health. 2015; 129:385–395. doi: 10.1016/j.puhe.2015.01.013</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Béjot Y, Bailly H, Durier J, Giroud M. Epidemiology of stroke in Europe and trends for the 21st century. Presse Med. 2016; 45(12 pt 2):e391–e398. doi: 10.1016/j.lpm.2016.10.003</mixed-citation><mixed-citation xml:lang="en">Béjot Y, Bailly H, Durier J, Giroud M. Epidemiology of stroke in Europe and trends for the 21st century. Presse Med. 2016; 45(12 pt 2):e391–e398. doi: 10.1016/j.lpm.2016.10.003</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">OECD. Mortality from heart disease and stroke. In: Health at a Glance: Europe 2016: State of Health in the EU Cycle. Paris: OECD Publishing; 2016.</mixed-citation><mixed-citation xml:lang="en">OECD. Mortality from heart disease and stroke. In: Health at a Glance: Europe 2016: State of Health in the EU Cycle. Paris: OECD Publishing; 2016.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world.Lancet Neurol. 2007; 6:182–187. doi: 10.1016/S1474-4422(07)70031-5</mixed-citation><mixed-citation xml:lang="en">Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world.Lancet Neurol. 2007; 6:182–187. doi: 10.1016/S1474-4422(07)70031-5</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030.PLoS Med. 2006; 3:e442. doi: 10.1371/journal.pmed.0030442</mixed-citation><mixed-citation xml:lang="en">Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030.PLoS Med. 2006; 3:e442. doi: 10.1371/journal.pmed.0030442</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.Lancet. 1997; 349:1498–1504. doi: 10.1016/S0140-6736(96)07492-2</mixed-citation><mixed-citation xml:lang="en">Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.Lancet. 1997; 349:1498–1504. doi: 10.1016/S0140-6736(96)07492-2</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2017 Revision, Methodology of the United Nations Population Estimates and Projections, Working Paper No. ESA/P/WP.250. New York: United Nations; 2017.</mixed-citation><mixed-citation xml:lang="en">United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2017 Revision, Methodology of the United Nations Population Estimates and Projections, Working Paper No. ESA/P/WP.250. New York: United Nations; 2017.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Asplund K. What MONICA told us about stroke.Lancet Neurol. 2005; 4:64–68. doi: 10.1016/S1474-4422(04)00967-6</mixed-citation><mixed-citation xml:lang="en">Asplund K. What MONICA told us about stroke.Lancet Neurol. 2005; 4:64–68. doi: 10.1016/S1474-4422(04)00967-6</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Truelsen T, Piechowski-Jóźwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: a review of available data.Eur J Neurol. 2006; 13:581–598. doi: 10.1111/j.1468-1331.2006.01138.x</mixed-citation><mixed-citation xml:lang="en">Truelsen T, Piechowski-Jóźwiak B, Bonita R, Mathers C, Bogousslavsky J, Boysen G. Stroke incidence and prevalence in Europe: a review of available data.Eur J Neurol. 2006; 13:581–598. doi: 10.1111/j.1468-1331.2006.01138.x</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Truelsen T, Begg S, Mathers CD, Satoh T. Global burden of cerebrovascular disease in the year 2000.In: GBD 2000 Working Paper. Geneva, Switzerland: WHO; 2002.</mixed-citation><mixed-citation xml:lang="en">Truelsen T, Begg S, Mathers CD, Satoh T. Global burden of cerebrovascular disease in the year 2000.In: GBD 2000 Working Paper. Geneva, Switzerland: WHO; 2002.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet, 2018; 392:2052–2090. doi: 10.1016/S0140-6736(18)31694-5</mixed-citation><mixed-citation xml:lang="en">Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet, 2018; 392:2052–2090. doi: 10.1016/S0140-6736(18)31694-5</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32:2735–2740. doi:10.1161/hs1201.100209</mixed-citation><mixed-citation xml:lang="en">Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU. Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke. 2001;32:2735–2740. doi:10.1161/hs1201.100209</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Gardener H, Sacco RL, Rundek T, Battistella V, Cheung YK, Elkind MSV. Race and ethnic disparities in stroke incidence in the Northern Manhattan Study. Stroke. 2020;51:1064–1069. doi: 10.1161/STROKEAHA.119.028806</mixed-citation><mixed-citation xml:lang="en">Gardener H, Sacco RL, Rundek T, Battistella V, Cheung YK, Elkind MSV. Race and ethnic disparities in stroke incidence in the Northern Manhattan Study. Stroke. 2020;51:1064–1069. doi: 10.1161/STROKEAHA.119.028806</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, et al. Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13:429–438. doi: 10.1016/S1474-4422(13)70310-7</mixed-citation><mixed-citation xml:lang="en">Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, et al. Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13:429–438. doi: 10.1016/S1474-4422(13)70310-7</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2019 update: a report from the American Heart Association. Circulation 2019;139:e56–e528.</mixed-citation><mixed-citation xml:lang="en">Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2019 update: a report from the American Heart Association. Circulation 2019;139:e56–e528.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008; 39:2396–2399. doi: 10.1161/STROKEAHA.107.505776.</mixed-citation><mixed-citation xml:lang="en">Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008; 39:2396–2399. doi: 10.1161/STROKEAHA.107.505776.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Qureshi AI, Ziai WC, Yahia AM, Mohammad Y, Sen S, Agarwal P, et al. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery. 2003; 52:1033–1039; discussion 1039.</mixed-citation><mixed-citation xml:lang="en">Qureshi AI, Ziai WC, Yahia AM, Mohammad Y, Sen S, Agarwal P, et al. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery. 2003; 52:1033–1039; discussion 1039.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Messas E, Goudot G, Halliday A, Sitruk J, Mirault T, Khider L, at al on behalf the ESC WG of Aorta &amp; Peripheral Vascular Diseases, Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review, European Heart Journal Supplements, Volume 22, Issue Supplement_M, November 2020, Pages M35–M42, https://doi.org/10.1093/eurheartj/suaa162</mixed-citation><mixed-citation xml:lang="en">Messas E, Goudot G, Halliday A, Sitruk J, Mirault T, Khider L, at al on behalf the ESC WG of Aorta &amp; Peripheral Vascular Diseases, Management of carotid stenosis for primary and secondary prevention of stroke: state-of-the-art 2020: a critical review, European Heart Journal Supplements, Volume 22, Issue Supplement_M, November 2020, Pages M35–M42, https://doi.org/10.1093/eurheartj/suaa162</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Schermerhorn ML, Liang P, Dakour-Aridi H, Kashyap VS, Wang GJ, Nolan BW, et al. In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2020 Jan. 71 (1):87-95.</mixed-citation><mixed-citation xml:lang="en">Schermerhorn ML, Liang P, Dakour-Aridi H, Kashyap VS, Wang GJ, Nolan BW, et al. In-hospital outcomes of transcarotid artery revascularization and carotid endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative. J Vasc Surg. 2020 Jan. 71 (1):87-95.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Uno M, Takai H, Yagi K, Matsubara S. Surgical Technique for Carotid Endarterectomy: Current Methods and Problems. Neurol Med Chir (Tokyo). 2020 Sep 15;60(9):419-428. doi: 10.2176/nmc.ra.2020-0111. Epub 2020 Aug 15. PMID: 32801277; PMCID: PMC7490601.</mixed-citation><mixed-citation xml:lang="en">Uno M, Takai H, Yagi K, Matsubara S. Surgical Technique for Carotid Endarterectomy: Current Methods and Problems. Neurol Med Chir (Tokyo). 2020 Sep 15;60(9):419-428. doi: 10.2176/nmc.ra.2020-0111. Epub 2020 Aug 15. PMID: 32801277; PMCID: PMC7490601.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Howard VJ, Meschia JF, Lal BK. Carotid revascularization and medical management for asymptomatic carotid stenosis: protocol of the CREST-2 clinical trials. Int J Stroke, 12 (2017), pp. 770-778.</mixed-citation><mixed-citation xml:lang="en">Howard VJ, Meschia JF, Lal BK. Carotid revascularization and medical management for asymptomatic carotid stenosis: protocol of the CREST-2 clinical trials. Int J Stroke, 12 (2017), pp. 770-778.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Ceornodolea AD, Bal R, Severens JL. Epidemiology and management of atrial fibrillation and stroke: review of data from four European countries. Stroke Res Treat 2017;2017:8593207.</mixed-citation><mixed-citation xml:lang="en">Ceornodolea AD, Bal R, Severens JL. Epidemiology and management of atrial fibrillation and stroke: review of data from four European countries. Stroke Res Treat 2017;2017:8593207.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Pistoia F, Sacco S, Tiseo C, Degan D, Ornello R, Carolei A. The epidemiology of atrial fibrillation and stroke. Cardiol Clin 2016;34:255–268.</mixed-citation><mixed-citation xml:lang="en">Pistoia F, Sacco S, Tiseo C, Degan D, Ornello R, Carolei A. The epidemiology of atrial fibrillation and stroke. Cardiol Clin 2016;34:255–268.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Lin H, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996;27:1760–1764.</mixed-citation><mixed-citation xml:lang="en">Lin H, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996;27:1760–1764.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Overvad TF, Nielsen PB, Lip GY. Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score. Eur Heart J Cardiovasc Pharmacother 2017;3:37–41.</mixed-citation><mixed-citation xml:lang="en">Overvad TF, Nielsen PB, Lip GY. Treatment thresholds for stroke prevention in atrial fibrillation: observations on the CHA2DS2-VASc score. Eur Heart J Cardiovasc Pharmacother 2017;3:37–41.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Frost L, Engholm G, Johnsen S, Moller H, Henneberg EW, Husted S. Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch Intern Med 2001;161:272–276.</mixed-citation><mixed-citation xml:lang="en">Frost L, Engholm G, Johnsen S, Moller H, Henneberg EW, Husted S. Incident thromboembolism in the aorta and the renal, mesenteric, pelvic, and extremity arteries after discharge from the hospital with a diagnosis of atrial fibrillation. Arch Intern Med 2001;161:272–276.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Germanova O, Shchukin Y, Germanov V, Galati G, Germanov A. Extrasystolic arrhythmia: is it an additional risk factor of atherosclerosis? Minerva Cardioangiol. 2021 Jan 11. doi: 10.23736/S0026-4725.20.05490-0. Epub ahead of print. PMID: 33427426.</mixed-citation><mixed-citation xml:lang="en">Germanova O, Shchukin Y, Germanov V, Galati G, Germanov A. Extrasystolic arrhythmia: is it an additional risk factor of atherosclerosis? Minerva Cardioangiol. 2021 Jan 11. doi: 10.23736/S0026-4725.20.05490-0. Epub ahead of print. PMID: 33427426.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Germanova O, Germanov VA, Shchukin YV, Germanov AV, Galati G. Device for modeling of intra-arterial circulation: application in experimental cardiology, European Heart Journal, Volume 42, Issue Supplement_1, October 2021, ehab724.0299, https://doi.org/10.1093/eurheartj/ehab724.0299</mixed-citation><mixed-citation xml:lang="en">Germanova O, Germanov VA, Shchukin YV, Germanov AV, Galati G. Device for modeling of intra-arterial circulation: application in experimental cardiology, European Heart Journal, Volume 42, Issue Supplement_1, October 2021, ehab724.0299, https://doi.org/10.1093/eurheartj/ehab724.0299</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Germanova OA, Germanov VA, Shchukin YuV, Germanov AV, Piskunov MV. Extrasystoles: adverse effects of the first postextrasystolic contraction. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 2020;(6):89-97. (In Russ.) https://doi.org/10.20340/vmi-rvz.2020.6.11</mixed-citation><mixed-citation xml:lang="en">Germanova OA, Germanov VA, Shchukin YuV, Germanov AV, Piskunov MV. Extrasystoles: adverse effects of the first postextrasystolic contraction. Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH). 2020;(6):89-97. (In Russ.) https://doi.org/10.20340/vmi-rvz.2020.6.11</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
